Literature DB >> 29119440

Compassionate Use of Bacteriophage Therapy for Foot Ulcer Treatment as an Effective Step for Moving Toward Clinical Trials.

Randolph Fish1,2, Elizabeth Kutter3,4, Gordon Wheat3,5, Bob Blasdel6, Mzia Kutateladze7, Sarah Kuhl8,9.   

Abstract

We here present detailed descriptions of successful treatment of a series of diabetic toe ulcers using the Eliava BioPreparations' commercial preparation of the very well-studied anti-staphylococcal bacteriophage Sb-1. This chapter outlines what we feel is an appropriate mechanism to speed movement toward full-scale clinical trials with bacteriophage use to treat wound infections and to help address the crisis in antibiotic resistance.

Entities:  

Keywords:  Amputation; Bacteriophage therapy; Debridement; Diabetic foot ulcers; Osteomyelitis

Mesh：

Year:  2018        PMID： 29119440     DOI： 10.1007/978-1-4939-7395-8_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  20 in total

1.  Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice.

Authors:  Nicolas Dufour; Raphaëlle Delattre; Anne Chevallereau; Jean-Damien Ricard; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 2.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

3.  [Interpretation of 2019 International Working Group on Diabetic Foot guidelines on the prevention and management of diabetic foot disease].

Authors:  Lei Gao; Jiangning Wang; Yefeng Yin
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-01-15

Review 4.  Challenges and innovations in treating chronic and acute wound infections: from basic science to clinical practice.

Authors:  Xiaotong Ding; Qinghan Tang; Zeyu Xu; Ye Xu; Hao Zhang; Dongfeng Zheng; Shuqin Wang; Qian Tan; Joanneke Maitz; Peter K Maitz; Shaoping Yin; Yiwei Wang; Jun Chen
Journal:  Burns Trauma       Date:  2022-05-21

5.  Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Tamta Tkhilaishvili; Tobias Winkler; Michael Müller; Carsten Perka; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 6.  Applications of Bacteriophages in the Treatment of Localized Infections in Humans.

Authors:  Vera V Morozova; Valentin V Vlassov; Nina V Tikunova
Journal:  Front Microbiol       Date:  2018-08-02       Impact factor: 5.640

Review 7.  Phage Therapy with a Focus on the Human Microbiota.

Authors:  Sharita Divya Ganeshan; Zeinab Hosseinidoust
Journal:  Antibiotics (Basel)       Date:  2019-08-27

Review 8.  Robust Approaches for the Production of Active Ingredient and Drug Product for Human Phage Therapy.

Authors:  Michele Mutti; Lorenzo Corsini
Journal:  Front Microbiol       Date:  2019-10-08       Impact factor: 5.640

Review 9.  Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections.

Authors:  Qian Xu; Xuefeng Hu; Yunbing Wang
Journal:  Mol Biotechnol       Date:  2021-07-26       Impact factor: 2.695

Review 10.  Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.

Authors:  Christine Rohde; Johannes Wittmann; Elizabeth Kutter
Journal:  Surg Infect (Larchmt)       Date:  2018-10-09       Impact factor: 2.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.